IP Verse

Tillotts Pharma Ag competitive analysis

Loading summary...

Latest oppositions filed by Tillotts Pharma Ag

Explore patent oppositions filed by Tillotts Pharma Ag against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 6, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2461802
Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture ThereofSOFARFeb 28, 2019
EP2611429
Mesalazine Tablet Having Improved DissolutionDISPHARNov 21, 2018
EP2552955
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 5, 2018

Latest patents of Tillotts Pharma Ag opposed by its competitors

Explore Tillotts Pharma Ag's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3459528
Nov 23, 2022Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering1

Latest PTAB cases involving Tillotts Pharma Ag

Discover the latest PTAB cases involving Tillotts Pharma Ag, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tillotts Pharma Ag with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TILLOTTS PHARMA31 - -
CHUGAI SEIYAKU KABUSHIKI KAISHA378 - 1
DISPHAR - 1 - -
HEIROTH1 - - -